Elevated Serum Levels of Cysteine and Tyrosine: Early Biomarkers in Asymptomatic Adults at Increased Risk of Developing Metabolic Syndrome
Table 1
Baseline characteristic and physiologic measures.
Variable
Group
MetS0 = 31
MetS1 = 35
MetS2 = 30
Baseline characteristics
Female
20 (65%)
24 (69%)
20 (67%)
Age (years)
36.6 ± 6.5
36.7 ± 5.6
39.5 ± 6.2
BMI (kg/m2)
21.6 ± 2.2
26.4 ± 4.2b
29.0 ± 3.5d,e
Waist circumference (cm)
74.1 ± 6.7
85.5 ± 9.2b
96.5 ± 8.4d,f
Waist/hip ratio
0.81 ± 0.07
0.85 ± 0.09a
0.90 ± 0.06d,e
ABSI (m11/6/kg2/3)
0.073 ± 0.005
0.074 ± 0.005
0.077 ± 0.004d,f
Systolic blood pres. (mmHg)
119 ± 14
122 ± 13
134 ± 20
Diastolic blood pres. (mmHg)
67 ± 6
73 ± 12
80 ± 12c
Pulse (rate/min)
58 ± 25
55 ± 29
66 ± 9c,e
Smoking (%)
Yes
19
17
10
No
81
83
90
Dietary intake
Total energy (kcal/day)
1950 ± 500
2050 ± 650
2100 ± 700
Total carbohydrate (g/day)
240 ± 70
250 ± 100
250 ± 100
Total fiber (g/day)
23 ± 11
21 ± 7
23 ± 10
Total protein (g/day)
75 ± 25
85 ± 30
90 ± 40c
Total fat (g/day)
75 ± 25
80 ± 30
80 ± 30
Total saturated fat (g/day)
23 ± 10
25 ± 10
28 ± 12
Polyunsaturated fat (g/day)
11 ± 5
11 ± 5
11 ± 6
Physical status
Fitness index
110 ± 15
90 ± 15a
80 ± 15c
Body composition
Body fat (%)
21.9 ± 6.6
29.9 ± 10.1a
35.6 ± 9.5d,e
Resting metabolic rate
RMR (kcal/day)
1470 ± 300
1440 ± 300
1450 ± 400
Insulin resistance
HOMA-IR
1.2 ± 0.5
1.4 ± 0.5
2.5 ± 1.2d,f
ABSI: a body shape index; BMI: body mass index; HOMA-IR: insulin resistance score; RMR: resting metabolic rate. Values are presented as means ± SD.
a,bGroup MetS1 is significantly different from group MetS0 at < 0.05 and < 0.001, respectively.
c,dGroup MetS2 is significantly different from group MetS0 at < 0.05 and < 0.001, respectively.
e,fGroup MetS2 is significantly different from group MetS1 at < 0.05 and < 0.001, respectively.